#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA615148	A	Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase	Rattus norvegicus	3	ALA1125500	assay format	Scientific Literature
2.	ALA620997	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 100 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
3.	ALA620998	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 150 mg/kg	Mus musculus	22	ALA1124898	organism-based format	Scientific Literature
4.	ALA620999	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 1600 mg/kg (intraperitoneal dosing for 8 days)	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
5.	ALA621000	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 200 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
6.	ALA621001	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 225 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
7.	ALA621002	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 270 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
8.	ALA621003	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 275 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
9.	ALA621004	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma, dosed for 10 days at 300 mg/kg	Mus musculus	114	ALA1124898	organism-based format	Scientific Literature
10.	ALA621005	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (intraperitoneal dosing for 8 days)	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
11.	ALA621006	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 300 mg/kg (ip dosing daily for 8 days)	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
12.	ALA621007	F	Antitumor activity in vivo against the 6C3HED lymphosarcoma dosed for 10 days at 600 mg/kg	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
13.	ALA621008	F	Percent inhibition against 6C3HED lymphosarcoma at dose 100 mg/kg in C3H mice	Mus musculus	1	ALA1124522	organism-based format	Scientific Literature
14.	ALA621009	F	Percent inhibition against 6C3HED lymphosarcoma at dose 12.5 mg/kg in C3H mice	Mus musculus	1	ALA1124522	organism-based format	Scientific Literature
15.	ALA857705	F	Percent inhibition against 6C3HED lymphosarcoma at dose 25 mg/kg in C3H mice	Mus musculus	1	ALA1124522	organism-based format	Scientific Literature
16.	ALA619828	F	Percent inhibition against 6C3HED lymphosarcoma at dose 50 mg/kg in C3H mice	Mus musculus	1	ALA1124522	organism-based format	Scientific Literature
17.	ALA619829	F	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 100 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
18.	ALA619830	F	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 10 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
19.	ALA619831	F	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 200 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature
20.	ALA619832	F	Tested on 6C3HED lymphosarcoma and percent inhibition was determined at 50 mg/kg dosage administered for 8 days intraperitoneally	Mus musculus	1	ALA1124898	organism-based format	Scientific Literature